- Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
- Dyadic Announces Change in Board and Management Leadership Roles
- Dyadic to Attend Industry Events in April
- Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
- Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
- Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
- CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
- Dyadic to Attend Industry Events in March
- Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
- Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
More ▼
Key statistics
On Wednesday, Dyadic International Inc (DYAI:NAQ) closed at 1.47, 23.53% above the 52 week low of 1.19 set on Jan 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.49 |
---|---|
High | 1.51 |
Low | 1.39 |
Bid | 1.20 |
Offer | 2.30 |
Previous close | 1.47 |
Average volume | 16.25k |
---|---|
Shares outstanding | 29.24m |
Free float | 20.29m |
P/E (TTM) | -- |
Market cap | 42.98m USD |
EPS (TTM) | -0.2359 USD |
Data delayed at least 15 minutes, as of May 01 2024 19:54 BST.
More ▼